White Pine Capital’s AbbVie ABBV Stock Holding History

White Pine Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Hold	5,717	–	–	0.34%	97
2026 Q1	$1.24M	Sell	5,717 -50	-0.9%	-$11.1K	0.34%	96
2025 Q4	$1.32M	Hold	5,767	–	–	0.36%	85
2025 Q3	$1.34M	Sell	5,767 -6	-0.1%	-$1.22K	0.38%	75
2025 Q2	$1.07M	Hold	5,773	–	–	0.34%	84
2025 Q1	$1.21M	Hold	5,773	–	–	0.42%	72
2024 Q4	$1.03M	Buy	5,773 +110	+2%	+$20.2K	0.35%	86
2024 Q3	$1.12M	Hold	5,663	–	–	0.38%	77
2024 Q2	$971K	Hold	5,663	–	–	0.37%	78
2024 Q1	$921K	Buy	5,663 +165	+3%	+$28.4K	0.35%	86
2023 Q4	$852K	Buy	5,498 +65	+1%	+$9.48K	0.33%	93
2023 Q3	$810K	Buy	5,433 +375	+7%	+$55.1K	0.33%	98
2023 Q2	$681K	Buy	5,058 +40	+0.8%	+$5.87K	0.25%	110
2023 Q1	$800K	Hold	5,018	–	–	0.31%	100
2022 Q4	$811K	Hold	5,018	–	–	0.32%	101
2022 Q3	$673K	Buy	5,018 +150	+3%	+$21.5K	0.28%	104
2022 Q2	$746K	Sell	4,868 -213	-4%	-$32.5K	0.29%	103
2022 Q1	$824K	Hold	5,081	–	–	0.26%	110
2021 Q4	$688K	Buy	5,081 +3	+0.1%	+$354	0.2%	131
2021 Q3	$548K	Hold	5,078	–	–	0.17%	148
2021 Q2	$591K	Hold	5,078	–	–	0.18%	143
2021 Q1	$550K	Hold	5,078	–	–	0.17%	143
2020 Q4	$544K	Buy	5,078 +10	+0.2%	+$961	0.19%	137
2020 Q3	$444K	Hold	5,068	–	–	0.18%	138
2020 Q2	$498K	Buy	5,068 +153	+3%	+$13.5K	0.21%	128
2020 Q1	$374K	Hold	4,915	–	–	0.19%	124
2019 Q4	$435K	Sell	4,915 -300	-6%	-$24.9K	0.17%	138
2019 Q3	$395K	Sell	5,215 -100	-2%	-$6.86K	0.15%	162
2019 Q2	$387K	Sell	5,315 -8,758	-62%	-$688K	0.14%	158
2019 Q1	$1.13M	Sell	14,073 -2,428	-15%	-$199K	0.42%	68
2018 Q4	$1.52M	Sell	16,501 -11,243	-41%	-$989K	0.63%	42
2018 Q3	$2.62M	Sell	27,744 -70	-0.3%	-$6.64K	0.93%	19
2018 Q2	$2.58M	Sell	27,814 -966	-3%	-$94.3K	0.92%	15
2018 Q1	$2.72M	Hold	28,780	–	–	1%	15
2017 Q4	$2.78M	Sell	28,780 -50	-0.2%	-$4.71K	1.02%	14
2017 Q3	$2.56M	Sell	28,830 -750	-3%	-$57.1K	0.99%	17
2017 Q2	$2.15M	Sell	29,580 -725	-2%	-$48.7K	0.85%	26
2017 Q1	$1.98M	Sell	30,305 -280	-0.9%	-$17.6K	0.8%	32
2016 Q4	$1.92M	Hold	30,585	–	–	0.81%	30
2016 Q3	$1.93M	Sell	30,585 -75	-0.2%	-$4.86K	0.82%	30
2016 Q2	$1.9M	Buy	30,660 +45	+0.1%	+$2.74K	0.8%	31
2016 Q1	$1.75M	Buy	30,615 +912	+3%	+$50.8K	0.75%	33
2015 Q4	$1.76M	Buy	29,703 +7,140	+32%	+$411K	0.78%	32
2015 Q3	$1.23M	Sell	22,563 -25	-0.1%	-$1.63K	0.57%	43
2015 Q2	$1.52M	Sell	22,588 -325	-1%	-$21.2K	0.65%	36
2015 Q1	$1.34M	Sell	22,913 -400	-2%	-$24.2K	0.54%	56
2014 Q4	$1.53M	Sell	23,313 -800	-3%	-$50.4K	0.51%	61
2014 Q3	$1.39M	Sell	24,113 -1,630	-6%	-$90.5K	0.47%	70
2014 Q2	$1.45M	Sell	25,743 -1,050	-4%	-$55.1K	0.5%	66
2014 Q1	$1.38M	Buy	26,793 +100	+0.4%	+$5.05K	0.47%	70
2013 Q4	$1.41M	Buy	26,693 +1,828	+7%	+$89.8K	0.5%	63
2013 Q3	$1.11M	Sell	24,865 -250	-1%	-$11.1K	0.38%	82
2013 Q2	$1.04M	Buy	+25,115	New	+$1.1M	0.36%	84

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

White Pine Capital's ABBV Position: Q2 2026 in Review

White Pine Capital held its AbbVie (ABBV) position steady in Q2 2026 at 5,717 shares worth $1.44M. The position accounts for 0.34% of the portfolio, ranked #97.

White Pine Capital first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.78M in Q4 2017. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

White Pine Capital held 5,717 shares of AbbVie worth $1.44M as of Q2 2026.
White Pine Capital left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.34% of White Pine Capital's portfolio in Q2 2026, its #97 holding.
White Pine Capital first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
White Pine Capital's AbbVie position peaked at $2.78M in Q4 2017.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on White Pine Capital's 13F filing for Q2 2026, filed 5 Aug 2026.